Back to search results

A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Stargardt Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Associated Retina Consultants, Phoenix, Arizona, United States

    Contact: Study coordinator (Study Team) · hello@doctrials.com
    Contact: Principal Investigator (Benjamin Bakall)

  • Retina Vitreous Associates Medical Group, Los Angeles, California, United States

    Contact: Study coordinator (Kristina Passoian, Trials Director) · Kpassoian@laretina.com
    Contact: Study coordinator (Study Referrals) · Studyreferrals@laretina.com
    Contact: Principal Investigator (David Liao)

  • Mayo Clinic, Rochester, Minnesota, United States

    Contact: Study coordinator (Suzy Wernimont) · Wernimont.Suzanne@mayo.edu · 507-538-8119
    Contact: Principal Investigator (Brittni Scruggs)

  • Retina Consultants of Texas, Bellaire, Texas, United States

    Contact: Principal Investigator (Kenneth Fan)

  • Retina Foundation of the Southwest, Dallas, Texas, United States

    Contact: Study coordinator (Senior Clinical Research Coordinator) · jclark@retinafoundation.org
    Contact: Principal Investigator (Karl Csaky)

  • University of Utah, Salt Lake City, Utah, United States

    Contact: Study coordinator (Kimberley Wegner Lead Coordinator) · Kimberley.wegner@hsc.utah.edu
    Contact: Principal Investigator (Paul Bernstein)

  • Moorfields Eye Hospital NHS Foundation Trust, London, England, United Kingdom

  • The Retina Clinic, London, England, United Kingdom

View source on ClinicalTrials.gov(opens in a new tab)